Strikingly, both the Kasumi-1 and SKNO-1 t(8;21) AML cell lines shared this trend, suggesting that these regulatory elements may be important in controlling the dosage of AML1-ETO for t(8;21) leukemic maintenance. Here, RUNX1 is linked to acute myeloid leukemia.